ArticleRSC advances2026
40 years later: completion of the structural characterization of the anxiolytic drug buspirone HCl and solid-form landscape expansion.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Buspirone (Bus) is an anxiolytic drug and was commercialized forty years ago as an HCl salt. The HCl salt of Bus is also polymorphic, and here, using electron diffraction, we reveal the structure of Bus·HCl Form 2 for the first time. We also prepared the first multicomponent solids of Bus, and describe 15 solids, including cocrystals, an ionic cocrystal, and salts. Significant differences in the solid-state conformation of Bus are described, as well as impacts to the thermal properties upon incorporation into multicomponent solids. Bus, like many drug molecules, does not include a classic ionizable group, which could hamper solid-state development. Bus does include a piperazine ring, one of the five most frequently used nitrogen-based heterocycles in US FDA approved drugs, and is a key site for forming intermolecular hydrogen bonds in each solid. The strategies here could be applied to modify properties in other piperazine-containing drugs.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.